tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports
Want to see AQST full AI Analyst Report?

Aquestive Therapeutics (AQST) Stock News & Sentiment

2,470 Followers
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
Premium
Market News
Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
22d ago
AQST
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 
Premium
Class Action
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline 
1M ago
AQST
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
Premium
Company Announcements
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
1M ago
8K
AQST
Aquestive Therapeutics Announces Key Legal Leadership Transition
Premium
Company Announcements
Aquestive Therapeutics Announces Key Legal Leadership Transition
2M ago
8K
AQST
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm
Premium
Class Action
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm
2M ago
AQST
Reiterating Buy on Aquestive: Near-Term Cost Pressures Offset by Anaphylm-Driven 2027 Growth Potential and $10 Target
Premium
Ratings
Reiterating Buy on Aquestive: Near-Term Cost Pressures Offset by Anaphylm-Driven 2027 Growth Potential and $10 Target
2M ago
AQST
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch
Premium
Company Announcements
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch
2M ago
AQST
More AQST News >

AQST News on the Web

Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
TipRanks News
Neutral
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Zacks
Bullish
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Insmed (INSM)
TipRanks News
Bullish
Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting
TipRanks News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Alumis Inc. (ALMS), Aquestive Therapeutics (AQST)
TipRanks News
Bullish
Aquestive Therapeutics completes Type A meeting with FDA for Anaphylm NDA
TipRanks News
Bullish
Aquestive Therapeutics Announces Key Legal Leadership Transition
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
AQST
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AQST’s Media Buzz Sentiment?
Currently, no data Available
What is AQST’s weekly average amount of articles?
Currently, no data Available
What is AQST’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week